copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Dalbavancin as long-term treatment in Corynebacterium striatum . . . Dalbavancin exhibited a more potent activity than vancomycin and daptomycin against most staphylococcal isolates, Bacillus spp , Micrococcus spp and various streptococci All 23 Corynebacterium spp isolates were inhibited by ⩽0 03 mg L of dalbavancin (range 0 008–0 03 mg L)
Comprehensive update of dalbavancin activity when tested against . . . Among all reported isolates, 99 8% of tested strains were inhibited at dalbavancin MIC values at ≤0 12 μg mL Dalbavancin remains very potent against rarer Gram-positive pathogens, using in vitro test experience with organisms cultured through 2011
Comprehensive update of dalbavancin activity when tested against . . . Like the streptococcal values (Table 1), dalbavancin was very active against Corynebacterium spp (MIC 50 90, 0 06 0 12 μg mL), L monocytogenes (MIC 50 90, 0 06 0 12 μg mL), and Micrococcus spp (MIC 50 90, ≤0 03 ≤0 03 μg mL)
Dalbavancin - Wikipedia Other Gram-positive organisms belonging to the Bacillus spp , Listeria spp , and Corynebacterium spp may show in vitro susceptibility, and dalbavancin may exhibit activity against enterococci expressing the VanB or VanC phenotype of acquired resistance against vancomycin